Calnexin‑Ab‑Onc
Metastatic solid tumors (pancreatic, lung, liver)
PreclinicalActive
Key Facts
Indication
Metastatic solid tumors (pancreatic, lung, liver)
Phase
Preclinical
Status
Active
Company
About Albatroz Therapeutics
Innovative antibodies targeting Calnexin to protect extracellular matrix and treat cancer, arthritis, and IBD.
View full company profile